Conflict of interest statement: There are no conflicts of interest.120. Acta Med Okayama. 2018 Apr;72(2):185-187. doi: 10.18926/AMO/55860.A Case of Psoriasis Complicated by Breast Cancer after Systemic TreatmentsIncluding Biologics.Morizane S(1), Sugimoto S, Motoki T, Katayama N, Omori M, Iwatsuki K.Author information: (1)Department of Dermatology, Okayama University Graduate School of Medicine,Dentistry and Pharmaceutical Sciences, Okayama 700-8558,Japan.zanemori@cc.okayama-u.ac.jp.Psoriasis is a common chronic inflammatory skin disorder that is characterized byscaly, erythematous, sharply demarcated plaques. The treatment for psoriasis has dramatically changed over the last 10 years with the introduction of biologics.However, the risk of cancer induced by biologics for psoriasis has not been fullyanalyzed, since these agents have such a short history of use. Here we report thecase of a 74-year-old woman with psoriasis vulgaris and psoriatic arthritiscomplicated by breast cancer after systemic treatments including etretinate,cyclosporine, methotrexate, adalimumab, and ustekinumab.DOI: 10.18926/AMO/55860 PMID: 29674768 